EGFR and head and neck squamous cell carcinoma: The impact of treatment sequence on therapeutic efficacy is emerging as a critical question in head and neck squamous cell carcinoma (HNSCC), where both anti-EGFR therapy and immunotherapy represent major therapeutic advances.2